CRVSCORVUS PHARMACEUTICALS INC
CUSIP 221015100 · common stock
3 tracked investors held CORVUS PHARMACEUTICALS INC (CRVS) at the end of Q3 2026, worth $42.2M in total. The largest holder was Perceptive Advisors, with 0.5% of its portfolio. Ken Fisher opened a new position this quarter.
Holders · Q3 2026
3
New holders
1
Value held
$42.2M
Quarter-end price (est.)
$11.52
Investors holding CRVS · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Perceptive Advisors Perceptive Advisors LLC | 0.50% | 2,510,441 | $28.9M | REDUCE-5.9% |
| Ken Fisher Fisher Asset Management, LLC | 0.00% | 1,040,606 | $12M | NEW |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.05% | 112,100 | $1.3M | REDUCE-4.3% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| RA Capital Management | 0.06% | 450,000 | $6.7M | EXIT |